LYRBX | MVCAX | LYRBX / MVCAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 11 years | 24 years | - |
Gain YTD | 4.020 | 0.391 | 1,028% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 1000 | 250% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.12B | 17.4B | 6% |
Annual Yield % from dividends | 0.20 | 1.16 | 17% |
Returns for 1 year | 12.40 | 1.20 | 1,036% |
Returns for 3 years | 23.96 | 3.99 | 601% |
Returns for 5 years | 63.09 | 28.23 | 224% |
Returns for 10 years | 63.42 | 60.23 | 105% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FISR | 25.64 | 0.09 | +0.37% |
SPDR® SSGA Fixed Inc Sect Rotation ETF | |||
FBT | 177.90 | -0.07 | -0.04% |
First Trust NYSE Arca Biotech ETF | |||
DGRO | 63.76 | -0.50 | -0.78% |
iShares Core Dividend Growth ETF | |||
IGTR | 25.12 | -0.45 | -1.75% |
Innovator Gradient Tactical Rot Str ETF | |||
ZHDG | 20.57 | -0.40 | -1.91% |
ZEGA Buy and Hedge ETF |